Indinavir (cipla Ltd)

Indinavir (cipla Ltd) (Indinavir)

Product Description

Indinavir is a medicine that is used for antiretroviral therapy (ART). This type of medicine stops the reproduction of HIV by inhibiting the work of the enzyme reverse transcriptase. Indinavir is a protease inhibitor. The HIV protease works like a chemical scissors. It divides the HIV source material into parts necessary to build a new virus. Protease inhibitors stop the work of these "scissors".

Safety information

Indications and usage

Diseases caused by HIV-1 in adults:

• Previously untreated antiretroviral drugs (in combination with antiretroviral drugs or in the form of monotherapy at the beginning of treatment for patients who are clinically unsuitable for the appointment of nucleoside analogues);
• Previously antiretroviral drugs and having contraindications or resistance to drugs - reverse transcriptase inhibitors (in combination with antiretroviral drugs or as monotherapy).

Mode of application

Intake, 1 hour before or 2 hours after eating, squeezed with water - 800 mg every 8 hours. The initial dose - 2.4 g/day.

With simultaneous use with rifabutin dose reduced by 2 times; it appoints with ketoconazole of 600 mg every 8 hours.

With hepatic insufficiency, cirrhosis, nephrourolythiasis - 600 mg every 8 hours.

Contraindications

Hypersensitivity, pregnancy, lactation.

Indinavir should be used with caution by patients with hemophilia, hepatic failure, children and old age (safety and efficacy is not established).

Side effects

• Asthenia, dizziness, headache, hypoesthesia, sleep disorders (drowsiness), nervousness, depression, paresthesia, tremor, peripheral polyneuropathy.
• Arthralgia, myalgia, muscle cramps, rigidity of limb muscles, chest pain.
• Cough, breathing disorder, sinusitis, upper respiratory infections, pneumonia.
• Dysuria, nocturia, nefrourolitiaz, kidney pain, hematuria, proteinuria, hypercreatininaemia.
• Dry skin, itching, dermatitis.
• Spontaneous bleeding in patients with hemophilia A and B.
• Lymphadenopathy, fever, increased sweating, flu-like syndrome, hemolytic anemia.